Abstract

Pharmaceutical manufacturing is rapidly advancing through continuous processes, Artificial Intelligence (AI), and digital technologies. This shift improves efficiency, product quality, and supply chain resilience. Key innovations include Process Analytical Technology (PAT), advanced process control, and sustainable practices. The industry navigates challenges in data integration, regulatory hurdles, and scalability, particularly in biologics. Ultimately, these transformations aim for more flexible, quality-driven, and environmentally responsible drug production methods, leveraging advanced materials for novel products.